Cambridge, United Kingdom

Elena De Angelis

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 19(Granted Patents)


Location History:

  • Stevenage, GB (2017)
  • Cambridge, GB (2014 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Elena De Angelis

Introduction

Elena De Angelis is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunology, particularly through her innovative work on anti-serum albumin binding variants. With a total of 7 patents to her name, her inventions have the potential to impact therapeutic applications significantly.

Latest Patents

Among her latest patents are two notable inventions related to improved variants of the anti-serum albumin immunoglobulin single variable domain. The first patent focuses on the variant DOM7h-11, which includes ligands and drug conjugates, as well as compositions, nucleic acids, vectors, and hosts. The second patent pertains to the variant DOM7h-14, which similarly encompasses ligands and drug conjugates, along with compositions, nucleic acids, vectors, and hosts.

Career Highlights

Elena has worked with reputable organizations, including Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. Her experience in these companies has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Elena has collaborated with notable colleagues, including Haiqun Liu and Oliver Schon. These partnerships have further enhanced her research and development efforts.

Conclusion

Elena De Angelis stands out as an influential inventor in the realm of immunology, with her innovative patents paving the way for advancements in therapeutic solutions. Her work continues to inspire and contribute to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…